82
Views
19
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis, spectroscopic, antimicrobial and anti-inflammatory studies of 5(2′-hydroxyphenyl)-3-(4-x-phenyl)pyrazolinates of copper(II) and their addition complexes with donor ligands

, , &
Pages 493-505 | Received 05 Mar 2008, Accepted 01 Apr 2008, Published online: 10 Dec 2009
 

Abstract

Complexes of copper(II) with 5(2′-hydroxyphenyl)-3-(4-x-phenyl)pyrazolines, (C15H12N2OX)2Cu [X =–H,–Cl,–CH3,–OCH3] have been synthesized with their addition complexes with 2,2′-bipyridine, 1,10-phenanthroline and triphenylphosphine. The complexes were characterized by elemental analyses, molecular weight measurement, magnetic, conductivity measurement, IR, electronic, 31P NMR, ESR and FAB mass spectra. The complexes were examined for crystalline/amorphous nature through XRD. Square-planar geometry around copper(II) is suggested with two bidentate pyrazoline ligands. In the additional complexes pyrazoline is monodentate. The bidentate and monodentate behavior of pyrazoline ligands was confirmed by IR and 31P NMR spectral data. All complexes were tested for in vitro antibacterial and antifungal activity and exhibit very good antibacterial and antifungal activity; coordination has a pronounced effect on the microbial activities. The brine shrimp bioassay was also carried out to study their in vitro cytotoxic properties. All complexes and adducts displayed potent cytotoxic activity against Artemia salina. Anti-inflammatory activity was also carried out by the carrageenan induced rat paw edema test. The complexes and adducts were found to have higher anti-inflammatory activity.

Acknowledgements

Authors are thankful to RSIC, CDRI, Lucknow (India), A.P.S. University, Rewa (India), SAIF, Indian Institute of Technology Bombay, Mumbai (India), SIF, IISC, Bangalore (India), Mahakal Institute of Pharmaceutical Studies, Ujjain (India) for providing spectral and analytical data.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.